Factor IX activity (1:10)

Factor IX is a vitamin K dependent clotting protein made in the liver. This test measures how well factor IX in your plasma works to help form a stable clot. The assay uses a standard dilution of your sample and reports activity as units per milliliter.

Clinicians use this test to evaluate unexplained bleeding or bruising, to diagnose hemophilia B, and to monitor treatment with factor IX concentrates. It can also help investigate abnormal screening clotting tests and conditions that affect the liver or vitamin K.

Knowing your factor IX activity helps identify hemophilia B and guides treatment planning, including preventive or on-demand infusions and perioperative care. If activity is reduced, you may be at higher risk for bleeding with injuries, dental work, or surgery, so targeted prevention can be arranged.

The test is also used when the activated partial thromboplastin time is prolonged, when there is a family history of bleeding, or when you take medicines that influence vitamin K or clotting. In some people, higher activity has been associated with a tendency to form clots, so results can inform decisions about monitoring and risk reduction.

If your activity is below the expected range, your clinician may repeat the test, review other clotting factors, and consider a mixing study to check for an inhibitor. Low activity can be inherited, as in hemophilia B, or acquired due to liver disease, vitamin K deficiency, or certain medications. Management depends on the cause and your symptoms, and may include factor replacement, vitamin K, or treating the underlying condition.

If your activity is higher than expected, it may reflect recent factor IX replacement, inflammation, pregnancy, or normal variation. A single result rarely determines treatment by itself. Your care team will interpret the result with your history, medications, and other labs, and may recommend follow-up testing or adjustments to your care plan.